Silexion Therapeutics Ltd.
SLXNW · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,187 | $4,595 | $8,259 | $39 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1,063 | $384 | $580 | $369 |
| Total Curr. Assets | $2,250 | $4,979 | $8,839 | $408 |
| Property Plant & Equip (Net) | $560 | $247 | $464 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $48 | $0 | $0 | $115,006 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $5 | $30 | $30 | $0 |
| Total NC Assets | $613 | $277 | $494 | $115,006 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,863 | $5,256 | $9,333 | $115,414 |
| Liabilities | – | – | – | – |
| Payables | $929 | $319 | $240 | $0 |
| Short-Term Debt | $1,162 | $112 | $115 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,432 | $1,765 | $1,255 | $349 |
| Total Curr. Liab. | $3,523 | $2,196 | $1,610 | $349 |
| LT Debt | $3,329 | $59 | $156 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $15,057 | $14,646 | $160 |
| Total NC Liab. | $3,329 | $15,116 | $14,802 | $160 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $526 | $171 | $271 | $0 |
| Total Liabilities | $6,852 | $17,312 | $16,412 | $509 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $2 | $1 | $1 | $115,000 |
| Retained Earnings | -$43,254 | -$26,811 | -$21,869 | -$951 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $39,263 | $11,334 | $11,203 | $856 |
| Total Equity | -$3,989 | -$15,476 | -$10,665 | $114,905 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $3,420 | $3,586 | $0 |
| Total Liab. & Tot. Equity | $2,863 | $5,256 | $9,333 | $115,414 |
| Net Debt | $3,304 | -$4,424 | -$7,988 | -$39 |